| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA39 |
| UNII: | 3S252O2Z4X |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interferon gamma inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphohistiocytosis, Hemophagocytic | 4 | D051359 | ClinicalTrials |
| Lymphohistiocytosis, Hemophagocytic | 4 | D051359 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Still's Disease, Adult-Onset | 3 | D016706 | ClinicalTrials |
| Macrophage Activation Syndrome | 3 | D055501 | ClinicalTrials |
| Immune System Diseases | 2 | D007154 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Granulomatous Disease, Chronic | 1 | D006105 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3989977 |
| FDA SRS | 3S252O2Z4X |
CONTENTS